Total planned funding: $149,959,885
Allocations
Countries/Regions
Ukraine | $149,959,885 |
Organizational Types
Unknown | $37,146,625 |
NGO | $31,994,886 |
Private Contractor | $31,181,491 |
Own Agency | $19,498,846 |
Multi-lateral Agency | $10,288,586 |
Implementing Agency | $6,525,040 |
University | $6,300,000 |
Other USG Agency | $5,424,411 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $58,851,015 |
Treatment | $30,301,200 |
Prevention | $18,702,253 |
Testing | $14,602,285 |
Management and Operations | $14,195,927 |
Care | $12,894,505 |
Budget Codes
OHSS: Health Systems Strengthening | $31,397,823 |
HTXS: Treatment: Adult Treatment | $18,763,029 |
HVSI: Strategic Information | $15,833,854 |
HVCT: Testing: HIV Testing and Counseling | $14,602,285 |
HVMS: Management and Operations | $14,195,927 |
HLAB: Laboratory Infrastructure | $11,619,338 |
HTXD: Treatment: ARV Drugs | $11,538,171 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,539,919 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,939,228 |
HVTB: Care: TB/HIV | $6,851,293 |
HBHC: Care: Adult Care and Support | $3,436,768 |
HMBL: Biomedical Prevention: Blood Safety | $2,747,249 |
HKID: Care: Orphans and Vulnerable Children | $2,606,444 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $182,500 |
PDTX: Treatment: Pediatric Treatment | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
Not Available:
$37,851,341
Countries/Regions
Chemonics International:
$19,792,383
Countries/Regions
USG Aggregated Agencies:
$18,149,846
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions